These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 22066010

  • 1. Pathobiological implications of MUC16 expression in pancreatic cancer.
    Haridas D, Chakraborty S, Ponnusamy MP, Lakshmanan I, Rachagani S, Cruz E, Kumar S, Das S, Lele SM, Anderson JM, Wittel UA, Hollingsworth MA, Batra SK.
    PLoS One; 2011; 6(10):e26839. PubMed ID: 22066010
    [Abstract] [Full Text] [Related]

  • 2. Mesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activation.
    Chen SH, Hung WC, Wang P, Paul C, Konstantopoulos K.
    Sci Rep; 2013; 3():1870. PubMed ID: 23694968
    [Abstract] [Full Text] [Related]

  • 3. DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.
    Lee J, Lee J, Yun JH, Jeong DG, Kim JH.
    Tumour Biol; 2016 Sep; 37(9):12193-12202. PubMed ID: 27230679
    [Abstract] [Full Text] [Related]

  • 4. Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma.
    Liang C, Qin Y, Zhang B, Ji S, Shi S, Xu W, Liu J, Xiang J, Liang D, Hu Q, Ni Q, Xu J, Yu X.
    Mol Cancer Res; 2017 Feb; 15(2):201-212. PubMed ID: 28108627
    [Abstract] [Full Text] [Related]

  • 5. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells.
    Das S, Rachagani S, Torres-Gonzalez MP, Lakshmanan I, Majhi PD, Smith LM, Wagner KU, Batra SK.
    Oncotarget; 2015 Mar 20; 6(8):5772-87. PubMed ID: 25691062
    [Abstract] [Full Text] [Related]

  • 6. The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC).
    Liu L, Xiang J, Chen R, Fu D, Hong D, Hao J, Li Y, Li J, Li S, Mou Y, Mai G, Ni Q, Peng L, Qin R, Qian H, Shao C, Sun B, Sun Y, Tao M, Tian B, Wang H, Wang J, Wang L, Wang W, Wang W, Zhang J, Zhao G, Zhou J, Yu X, Chinese Study Group for Pancreatic Cancer (CSPAC).
    Int J Oncol; 2016 Mar 20; 48(3):900-7. PubMed ID: 26718269
    [Abstract] [Full Text] [Related]

  • 7. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.
    Shukla SK, Gunda V, Abrego J, Haridas D, Mishra A, Souchek J, Chaika NV, Yu F, Sasson AR, Lazenby AJ, Batra SK, Singh PK.
    Oncotarget; 2015 Aug 07; 6(22):19118-31. PubMed ID: 26046375
    [Abstract] [Full Text] [Related]

  • 8. MUC16 Promotes Liver Metastasis of Pancreatic Ductal Adenocarcinoma by Upregulating NRP2-Associated Cell Adhesion.
    Marimuthu S, Lakshmanan I, Muniyan S, Gautam SK, Nimmakayala RK, Rauth S, Atri P, Shah A, Bhyravbhatla N, Mallya K, Grandgenett PM, Hollingsworth MA, Datta K, Jain M, Ponnusamy MP, Batra SK.
    Mol Cancer Res; 2022 Aug 05; 20(8):1208-1221. PubMed ID: 35533267
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.
    Radhakrishnan P, Mohr AM, Grandgenett PM, Steele MM, Batra SK, Hollingsworth MA.
    PLoS One; 2013 Aug 05; 8(10):e73356. PubMed ID: 24204560
    [Abstract] [Full Text] [Related]

  • 10. Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway.
    Matte I, Garde-Granger P, Bessette P, Piché A.
    BMC Cancer; 2019 Apr 30; 19(1):406. PubMed ID: 31039761
    [Abstract] [Full Text] [Related]

  • 11. Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma.
    Shimizu A, Hirono S, Tani M, Kawai M, Okada K, Miyazawa M, Kitahata Y, Nakamura Y, Noda T, Yokoyama S, Yamaue H.
    Cancer Sci; 2012 Apr 30; 103(4):739-46. PubMed ID: 22320398
    [Abstract] [Full Text] [Related]

  • 12. CA-125, but not galectin-3, complements CA 19-9 for discriminating ductal adenocarcinoma versus non-malignant pancreatic diseases.
    Coppin L, Benomar K, Corfiotti F, Cattan S, Renaud F, Lapere C, Leteurtre E, Vantyghem MC, Truant S, Pigny P.
    Pancreatology; 2016 Apr 30; 16(1):115-20. PubMed ID: 26613889
    [Abstract] [Full Text] [Related]

  • 13. Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.
    Horn A, Chakraborty S, Dey P, Haridas D, Souchek J, Batra SK, Lele SM.
    Arch Pathol Lab Med; 2013 Apr 30; 137(4):546-51. PubMed ID: 23544943
    [Abstract] [Full Text] [Related]

  • 14. Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer.
    Thomas D, Sagar S, Liu X, Lee HR, Grunkemeyer JA, Grandgenett PM, Caffrey T, O'Connell KA, Swanson B, Marcos-Silva L, Steentoft C, Wandall HH, Maurer HC, Peng XL, Yeh JJ, Qiu F, Yu F, Madiyalakan R, Olive KP, Mandel U, Clausen H, Hollingsworth MA, Radhakrishnan P.
    Mol Ther; 2021 Apr 07; 29(4):1557-1571. PubMed ID: 33359791
    [Abstract] [Full Text] [Related]

  • 15. Mucin 16 is a functional selectin ligand on pancreatic cancer cells.
    Chen SH, Dallas MR, Balzer EM, Konstantopoulos K.
    FASEB J; 2012 Mar 07; 26(3):1349-59. PubMed ID: 22159147
    [Abstract] [Full Text] [Related]

  • 16. MUC16 mucin is expressed by the human ocular surface epithelia and carries the H185 carbohydrate epitope.
    Argüeso P, Spurr-Michaud S, Russo CL, Tisdale A, Gipson IK.
    Invest Ophthalmol Vis Sci; 2003 Jun 07; 44(6):2487-95. PubMed ID: 12766047
    [Abstract] [Full Text] [Related]

  • 17. Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion.
    Rao TD, Tian H, Ma X, Yan X, Thapi S, Schultz N, Rosales N, Monette S, Wang A, Hyman DM, Levine DA, Solit D, Spriggs DR.
    PLoS One; 2015 Jun 07; 10(5):e0126633. PubMed ID: 25965947
    [Abstract] [Full Text] [Related]

  • 18. Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.
    Shibahara H, Higashi M, Koriyama C, Yokoyama S, Kitazono I, Kurumiya Y, Narita M, Kuze S, Kyokane T, Mita S, Arai T, Kato T, Yuasa N, Yamaguchi R, Kubota H, Suzuki H, Baba S, Rousseau K, Batra SK, Yonezawa S.
    PLoS One; 2014 Jun 07; 9(4):e86111. PubMed ID: 24722639
    [Abstract] [Full Text] [Related]

  • 19. MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells.
    Lakshmanan I, Ponnusamy MP, Das S, Chakraborty S, Haridas D, Mukhopadhyay P, Lele SM, Batra SK.
    Oncogene; 2012 Feb 16; 31(7):805-17. PubMed ID: 21785467
    [Abstract] [Full Text] [Related]

  • 20. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to tumor-associated Treg enrichment in pancreatic cancer.
    Fan K, Yang C, Fan Z, Huang Q, Zhang Y, Cheng H, Jin K, Lu Y, Wang Z, Luo G, Yu X, Liu C.
    Cancer Lett; 2018 Apr 01; 418():167-175. PubMed ID: 29337110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.